Skip to main content

Three Tips for Providers Following the Bundled Payment Delay

What can you do while CMS decides how to handle the mandatory program?

As the healthcare community continues its march away from fee-for-service models, bundled payment initiatives have risen in popularity—thanks in no small part to their ability to fuel cost savings and significantly improve care outcomes.

The Centers for Medicare and Medicaid Services (CMS) issued an interim final rule in March that delays implementation of the new bundled payment model for heart attack and cardiac bypass surgery services; expansion of the existing Comprehensive Care for Joint Replacement bundling model; and implementation of a new cardiac rehabilitation incentive payment model, from July 1 to October 1, 2017.

Prior to the interim rule, CMS’ push forward on bundled payments focused the industry on episodic efficiency. The delay has pushed these initiatives back three months and, as DataGen’s Vice President, Kelly Price recently explained, is causing confusion and worry among participants.

Benefits of the delay

Despite Health and Human Services Secretary Tom Price’s negative statements about mandatory bundling initiatives, the delay has some benefits. Stakeholders across the industry will have more time to assess the efficacy of the program and provide comments to CMS. In addition, Secretary Price and others hope to align the payment periods with the calendar year. Providers can use this opportunity to better prepare for the program’s official start.

Will value-based care survive this overhaul?

Patrick Conway, Chief Medical Officer at CMS, has indicated that early findings around bundles are “encouraging,” but more data are needed to fully assess their impact on costs and quality. This validates CMS’ plans to test pilot bundles.

Industry experts think there is little reason to worry that bundled payment programs and other quality payment programs, such as those under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), are in danger of being decimated. The fact that MACRA was passed through a bipartisan vote indicates that Republicans and Democrats understand that there is a need to lower spending and shift away from fee-for-service toward value-based care. However, experts believe there might be a shift from mandatory bundles to voluntary bundles as it facilitates increased provider participation.

What should participants do now?

  1. Provider organizations that had previously expressed concern about the accelerated pace of the program can leverage this extra time to strengthen engagement with their patient populations. 
  2. Hospitals that will be participating in these programs can begin implementing test strategies to understand what would drive bundled payment profitability. Some factors to consider: 
    1. Program costs: These would include staff, marketing outreach to physicians, and information technology improvements. 
    2. Price discount: Providers may have a false sense of confidence if their historic spend is commensurate with the region rather than above that region. However, with a discount factor of 3% taken to calculate targets, those providers are already behind. 
    3. Gainsharing: While gainsharing is not allowed outside of the waivers in CMS’ bundling programs, providers can begin defining and discussing the parameters of a successful arrangement. Savings can be split by creating gainsharing incentives among the different stakeholders across the continuum. This will allow physicians to collaborate on the modalities they use to treat their patients. 
  3. Though it may be a long process, providers should begin educating senior leadership and setting appropriate expectations. While the concepts sound simple, in-depth exposure and discussion is needed to truly understand the implications of these new rules. 
At the same time, the CMS Innovation Center can use this extra time to test and evaluate these innovations in care delivery and payment and determine whether modifications are needed. CMS can also continue to examine the effectiveness of both mandatory and voluntary bundles to observe which route promotes increased participation and better incentives.

The delay raises several questions about what value-based care will look like under the Trump Administration. Even though it gives more time to stakeholders to review and test these programs comprehensively (and hopefully increase the chances of success under this model), it also could impede innovation, which would further drive up healthcare costs. We hope the latter is not the case.

Contact DataGen to learn more about bundled payment programs. Also, visit our Resources page and follow us on LinkedIn for more learning on healthcare payment reform.

Popular posts from this blog

How to prepare: Radiation Oncology Model, Part 1

Check your participation status and build your plan Are you a hospital outpatient department, physician group practice or freestanding clinic providing radiation therapy services? If so, you may be required to adopt the new mandatory Radiation Oncology Model. Mandatory participation is randomized by Core-based Statistical Areas. You can check your organization’s participation status online. CMS released the Final Rule for the RO Model, giving providers 60 days to prepare for program launch on January 1, 2022. If your organization performs radiation therapy in a ZIP code on the list, you will need to begin preparing for the model.

Proposed rule updates for the Radiation Oncology Model

The new Radiation Oncology alternative payment model will start Jan. 1, 2022, after the proposal is finalized in the calendar year 2022 Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System final rule, scheduled for early November. This rule will require prospective hospital outpatient departments, physician practices and freestanding clinics providing radiation therapy services to adopt a prospective bundled payment model with new clinical and quality measure reporting requirements. The model is mandatory for participants selected by CMS. The new RO model includes several notable changes that must be addressed for successful participation: Disease sites update The criteria for cancer types have been clarified. Cancer types must be: commonly treated with radiation therapy according to nationally recognized evidence-based guidelines; associated with ICD-10 codes that demonstrate pricing stability; and not determined to be unsuitable for inclusion by the H

What to know about CMS’ 2022 rules

Key takeaways from five final and two proposed rules from CMS CMS adopted five final Medicare Prospective Payment System rules for FFY 2022 and proposed two rules for calendar year 2022. DataGen has interpreted and analyzed each of the final and proposed rules to help you gauge how these changes may impact your organization.   These rules include regular updates to the wage index and other significant items listed below. The Inpatient PPS final rule includes the following proposals: rebasing and revising the IPPS marketbasket and the Capital Input Price Index from FFY 2014 cost report data to FFY 2018 data; rate increase (+0.5%) for the Medicare Access and CHIP Reauthorization Act of 2015 coding offset adjustment; nonstandard adjustments to hospital wage indexes (for eligible hospitals) including bottom quartile adjustments, a 5% wage index “stop-loss” and the reintroduction of an imputed floor policy as mandated by the Consolidated Appropriations Act of 2021; updates to Medicare Dis